| 1 |
2024 |
Gökçe Şeker Karatoprak, Berrak Dumlupınar, Engin Celep, Inci Kurt Celep, Esra Küpeli Akkol, Eduardo Sobarzo-Sánchez. A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers, Frontiers in Pharmacology. 2024; 15: 1423480.
https://doi.org/10.3389/fphar.2024.1423480 |
| 2 |
2024 |
Maurizio Capuozzo, Francesco Ferrara, Claudia Cinque, Stefania Farace, Domenico Lauritano, Alessandro Ottaiano. Navigating immunotherapy for ovarian cancer: current landscape and future perspectives, Journal of Cancer Metastasis and Treatment. 2024;
https://doi.org/10.20517/2394-4722.2024.38 |
| 3 |
2025 |
Mahima Raj, Abha Meena, Richa Seth, Anurag Mathur, Suaib Luqman. An update on nanoformulations with FDA approved drugs for female reproductive cancer, Journal of Microencapsulation. 2025; 1.
https://doi.org/10.1080/02652048.2025.2474457 |
| 4 |
2025 |
Cecilia Nasso, Silvia Puglisi, Sara Elena Rebuzzi, Veronica Errigo, Francesca Rosa, Ilaria Chiola, Caterina Lazzari, Yuri Musizzano, Ezio Venturino, Alessandro Gastaldo, Caterina Siccardi, Eugenio Oreste Volpi, Serafina Mammoliti, Marco Benasso. Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials, Immunotherapy. 2025; 17: 57.
https://doi.org/10.1080/1750743X.2025.2460964 |
| 5 |
2024 |
Yuke Wu, Xiang He. Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review, Clinical and Experimental Obstetrics & Gynecology. 2024; 51: 155.
https://doi.org/10.31083/j.ceog5107155 |
